Publicaciones en las que colabora con Oscar P. Kuipers (33)

2024

  1. Uncovering the diversity and distribution of biosynthetic gene clusters of prochlorosins and other putative RiPPs in marine Synechococcus strains

    Microbiology Spectrum, Vol. 12, Núm. 1

2023

  1. Advances in the preclinical characterization of the antimicrobial peptide AS-48

    Frontiers in Microbiology, Vol. 14

  2. Investigating the Specificity of the Dehydration and Cyclization Reactions in Engineered Lanthipeptides by Synechococcal SyncM

    ACS Synthetic Biology, Vol. 12, Núm. 1, pp. 164-177

  3. Synthesis and antimicrobial activity of aminoalkyl resveratrol derivatives inspired by cationic peptides

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 38, Núm. 1, pp. 267-281

2022

  1. Chemically Tuning Resveratrol for the Effective Killing of Gram-Positive Pathogens

    Journal of Natural Products, Vol. 85, Núm. 6, pp. 1459-1473

  2. G-Quadruplex DNA as a Target in Pathogenic Bacteria: Efficacy of an Extended Naphthalene Diimide Ligand and Its Mode of Action

    Journal of Medicinal Chemistry, Vol. 65, Núm. 6, pp. 4752-4766

2021

  1. Elucidating the mechanism by which synthetic helper peptides sensitize Pseudomonas aeruginosa to multiple antibiotics

    PLoS Pathogens, Vol. 17, Núm. 9

  2. Functional Expression and Characterization of the Highly Promiscuous Lanthipeptide Synthetase SyncM, Enabling the Production of Lanthipeptides with a Broad Range of Ring Topologies

    ACS Synthetic Biology, Vol. 10, Núm. 10, pp. 2579-2591

  3. New developments in RiPP discovery, enzymology and engineering

    Natural Product Reports, Vol. 38, Núm. 1, pp. 130-239

  4. Outer-membrane-acting peptides and lipid II-targeting antibiotics cooperatively kill Gram-negative pathogens

    Communications Biology, Vol. 4, Núm. 1

  5. The cathelicidin-derived close-to-nature peptide D-11 sensitises Klebsiella pneumoniae to a range of antibiotics in vitro, ex vivo and in vivo

    International Journal of Antimicrobial Agents, Vol. 58, Núm. 5

2020

  1. High-Throughput Screening for Substrate Specificity-Adapted Mutants of the Nisin Dehydratase NisB

    ACS Synthetic Biology, Vol. 9, Núm. 6, pp. 1468-1478

2019

  1. Adaption to glucose limitation is modulated by the pleotropic regulator CcpA, independent of selection pressure strength

    BMC Evolutionary Biology, Vol. 19, Núm. 1

  2. Analysis of modular bioengineered antimicrobial lanthipeptides at nanoliter scale

    Nature Chemical Biology, Vol. 15, Núm. 5, pp. 437-443

  3. Design and Expression of Specific Hybrid Lantibiotics Active Against Pathogenic Clostridium spp.

    Frontiers in Microbiology, Vol. 10

  4. Feasability of introducing a thioether ring in vasopressin by nisBTC co-expression in Lactococcus lactis

    Frontiers in Microbiology, Vol. 10, Núm. JUL

2018

  1. Increasing the antimicrobial activity of nisinbased lantibiotics against Gram-negative pathogens

    Applied and Environmental Microbiology, Vol. 84, Núm. 12

  2. Specificity and application of the lantibiotic protease NisP

    Frontiers in Microbiology, Vol. 9, Núm. FEB

2017

  1. Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials

    FEMS Microbiology Reviews, Vol. 41, Núm. 1, pp. 5-18

  2. Genome-guided identification of novel head-to-tail cyclized antimicrobial peptides, exemplified by the discovery of pumilarin

    Microbial Genomics, Vol. 3, Núm. 10